NAT-BENDAMUSTINE POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

nat-bendamustine powder for solution

natco pharma (canada) inc - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

bendamustine hydrochloride for injection powder for solution

jamp pharma corporation - bendamustine hydrochloride - powder for solution - 25mg - bendamustine hydrochloride 25mg - antineoplastic agents

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

bendamustine hydrochloride for injection powder for solution

jamp pharma corporation - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

bendamustine hydrochloride for injection powder for solution

auro pharma inc - bendamustine hydrochloride - powder for solution - 25mg - bendamustine hydrochloride 25mg - antineoplastic agents

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

bendamustine hydrochloride for injection powder for solution

auro pharma inc - bendamustine hydrochloride - powder for solution - 100mg - bendamustine hydrochloride 100mg - antineoplastic agents

BENDAMUSTINE HYDROCHLORIDE- bendamustine hydrochloride injection Marekani - Kiingereza - NLM (National Library of Medicine)

bendamustine hydrochloride- bendamustine hydrochloride injection

eagle pharmaceuticals, inc - bendamustine hydrochloride (unii: 981y8sx18m) (bendamustine - unii:9266d9p3pq) - bendamustine hydrochloride injection is indicated for the treatment of patients with chronic lymphocytic leukemia. efficacy relative to first line therapies other than chlorambucil has not been established. bendamustine hydrochloride injection is indicated for the treatment of patients with indolent b-cell non-hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. bendamustine hydrochloride injection is contraindicated in patients with a known hypersensitivity (e.g., anaphylactic and anaphylactoid reactions) to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol. [see warnings and precautions (5.3)] pregnancy category d [see warnings and precautions (5.9)] risk summary bendamustine hydrochloride can cause fetal harm when administered to a pregnant woman. bendamustine caused malformations in animals, when a single dose was administered to pregnant animals. advise women to avoid becoming pregnant while receiving be